Pivotal BE trial power not enough to 0.8 [Power / Sample Size]

posted by ElMaestro  – Denmark, 2017-09-22 09:46 (2399 d 19:15 ago) – Posting: # 17825
Views: 3,684

Hi Ssussu,

❝ (...) unluckily, the intrasubject CV from pivotal BE trial was larger than pilot trial, however, CI90 and point estimate were totally met the acceptance of Bioequivalence,only except the powerTOST from pivotal trial was less than 0.8.

❝ Then, in this situation, can i make conclusion of bioequivalence? Is there any guidance to support my conclusion?


Yes you have shown BE. Every guidance I can think of supports that conclusion, mainly because sample size calculation via power is based on an assumption about GMR and CV prior to the trial itself. Whether that assumption seems to hold true once the trial has been conducted is immaterial for the comparability; what is important is the confidence interval itself.

Pat yourself on the shoulder. :-)

Pass or fail!
ElMaestro

Complete thread:

UA Flag
Activity
 Admin contact
22,986 posts in 4,823 threads, 1,656 registered users;
54 visitors (0 registered, 54 guests [including 4 identified bots]).
Forum time: 05:01 CEST (Europe/Vienna)

Art is “I”; science is “we”.    Claude Bernard

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5